Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
Clinical Trial
SBP GROUP (01177.HK): LM-364 "Nectin-4ᵀᴹᴱ ADC" Obtains Clinical Trial Approvals from NMPA and FDA, Accelerating Global Clinical Development
Tags:
SBP GROUP
01177.HK
Clinical Trial
2026-08-28
IMMUNEONCO-B (01541.HK): First patient dosed in Phase II trial of IMM2510 plus IMM27M as first-line treatment for advanced HCC
Tags:
IMMUNEONCO-B
01541.HK
Clinical Trial
2026-08-27
CSPC PHARMA (01093.HK): High-potency amylin receptor agonist SYH2092 injection approved for clinical trials in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-08-27
BOAN BIOTECH (06955.HK): IND application for BA2201 (TL1A/IL-23) accepted by CDE
Tags:
BOAN BIOTECH
06955.HK
Clinical Trial
2026-08-26
CSPC PHARMA (01093.HK): SYS6010 meets primary endpoint in Phase III study for EGFR-mutant NSCLC after EGFR TKI failure
Tags:
CSPC PHARMA
01093.HK
R&D Progress
Clinical Trial
2026-08-26
BAO PHARMA-B (02659.HK): IND for KJ015 injection (anti-HER2 bispecific antibody subcutaneous formulation) approved by US FDA
Tags:
BAO PHARMA-B
02659.HK
Clinical Trial
2026-08-24
CSTONE PHARMA-B (02616.HK): IND of CS5007 (EGFR/HER3 bispecific ADC) approved by NMPA, fast-tracked in 23 working days
Tags:
CSTONE PHARMA-B
02616.HK
Clinical Trial
2026-08-21
GENFLEET-B (02595.HK): two first-in-class pancreatic cancer combination therapies of GFH375 advance to Phase II studies
Tags:
GENFLEET-B
02595.HK
Clinical Trial
2026-08-20
ABBISKO-B (02256.HK): IND application of oral pan-KRAS inhibitor ABSK211 approved by NMPA
Tags:
ABBISKO-B
02256.HK
Clinical Trial
2026-08-19
HBM HOLDINGS-B (02142.HK): IND application of HBM7004 for advanced solid tumors approved by NMPA
Tags:
HBM HOLDINGS-B
02142.HK
Clinical Trial
2026-08-18
HUTCHMED (00013.HK): ORPATHYS® + TAGRISSO® combination shows statistically and clinically meaningful PFS and OS improvement in MET-driven EGFR-mutated lung cancer
Tags:
HUTCHMED
00013.HK
Clinical Trial
2026-08-17
HANSOH PHARMA (03692.HK): Self-Developed Class 1 New Drug HS-10582 Tablet Receives NMPA Clinical Trial Approval Notice for Primary Hypercholesterolemia
Tags:
HANSOH PHARMA
03692.HK
Clinical Trial
2026-08-06
LUYE PHARMA(02186.HK): Innovative Drug LY03015 Completes Bridging Clinical Trial in the US, Pivoting to Efficacy‑focused Clinical Study
Tags:
LUYE PHARMA
02186.HK
Clinical Trial
2026-08-05
LEADS BIOLABS-B(09887.HK): Partner Oblenio Bio Completes First‑in‑Human Phase Ia First‑Patient Dosing of LBL‑051 for Refractory Autoimmune Diseases
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Trial
2026-08-04
HENGRUI PHARMA(01276.HK): SHR‑A2009 for Injection Combined with Adebrelimab Obtains NMPA Clinical Trial Approval for Non‑Small‑Cell Lung Cancer
Tags:
HENGRUI PHARMA
01276.HK
Clinical Trial
2026-08-04
HAIXI PHARMA(02637.HK): HX9428 for nAMD Cleared by US‑FDA for Phase II Trial; Positive‑Control Phase II Study Initiated in China
Tags:
HAIXI PHARMA
02637.HK
Clinical Trial
2026-08-04
ALPHAMAB-B(09966.HK): CDE Grants Approval for Phase III Clinical Trial of JSKN033 in Cervical Cancer
Tags:
ALPHAMAB-B
09966.HK
Clinical Trial
2026-08-03
CSPC PHARMA(01093.HK): Phase Ib/II Clinical Trial of SYS6090 Injection for Colorectal Cancer Initiated at First Study Centre in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-08-03
Ascletis-B (01672.HK): Oral Small-molecule GLP-1 ASC30 Initiates Global Phase III Clinical Trials; First-in-class Triple-target FDC Achieves 15.2% Weight Loss in Preclinical Studies
Tags:
ASCLETIS-B
01672.HK
Clinical Trial
2026-08-03
Henlius (02696.HK): NMPA Approves Clinical Trial Application for HLX43 Combined with Bevacizumab in Solid Tumors
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-31
Previous
1
2
3
4
5
Next
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App